Therapeutic Drug Monitoring of Imatinib - How Far Are We in the Leukemia Setting?

Anna Sofie Buhl Rasmussen,Christen Lykkegaard Andersen, Allan Weimann, Tianwu Yang,Camille Tron,Virginie Gandemer,Kim Dalhoff,Cecilie Utke Rank,Kjeld Schmiegelow

EXPERT REVIEW OF CLINICAL PHARMACOLOGY（2024）

引用 0|浏览2

暂无评分

关键词

ABL-class leukemia,acute lymphoblastic leukemia,chronic myeloid leukemia,imatinib,Philadelphia chromosome-like,Philadelphia chromosome positive,therapeutic drug monitoring,tyrosine kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要